1. A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism;van der Mooren MJ; C, Klipping; van Aken B; E, Helmerhorst; D, Spielmann; C, Kluft;Eur J Contracept Reprod Health Care,1999
2. The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg;322, Gestodene Study Group;Eur J Contracept Reprod Health Care,1999
3. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women;Hirvonen, E.; Stenman, U.H.; Mälkönen, M.; Rasi, V.; Vartiainen, E.; Ylöstalo, P.;Maturitas,1988
4. Efficacy and tolerability of a combined oral contraceptive containing 17 beta-estradiol and desogestrel;Kivinen, S.; Saure, A.;Eur J Contracept Reprod Health Care,1996
5. National Agency for Medicines. Femilar tablets: Summary of Product Characteristics [in Finnish];[3 May 2009].,2007